Faes Farma SA
MAD:FAE
Intrinsic Value
Faes Farma SA operates as a pharmaceutical company. [ Read More ]
The intrinsic value of one FAE stock under the Base Case scenario is hidden EUR. Compared to the current market price of 3.66 EUR, Faes Farma SA is hidden .
Valuation Backtest
Faes Farma SA
Run backtest to discover the historical profit from buying and selling FAE stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Faes Farma SA
Current Assets | 290.3m |
Cash & Short-Term Investments | 47.8m |
Receivables | 113.5m |
Other Current Assets | 129m |
Non-Current Assets | 485.7m |
Long-Term Investments | 1.9m |
PP&E | 280.6m |
Intangibles | 184.2m |
Other Non-Current Assets | 19m |
Current Liabilities | 86.8m |
Accounts Payable | 35.4m |
Accrued Liabilities | 13.2m |
Short-Term Debt | 12.1m |
Other Current Liabilities | 26.1m |
Non-Current Liabilities | 26.9m |
Long-Term Debt | 4.4m |
Other Non-Current Liabilities | 22.5m |
Earnings Waterfall
Faes Farma SA
Revenue
|
463.9m
EUR
|
Cost of Revenue
|
-156.8m
EUR
|
Gross Profit
|
307m
EUR
|
Operating Expenses
|
-200.8m
EUR
|
Operating Income
|
106.2m
EUR
|
Other Expenses
|
-11.4m
EUR
|
Net Income
|
94.8m
EUR
|
Free Cash Flow Analysis
Faes Farma SA
FAE Profitability Score
Profitability Due Diligence
Faes Farma SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Faes Farma SA's profitability score is hidden . The higher the profitability score, the more profitable the company is.
FAE Solvency Score
Solvency Due Diligence
Faes Farma SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Faes Farma SA's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FAE Price Targets Summary
Faes Farma SA
According to Wall Street analysts, the average 1-year price target for FAE is 3.97 EUR with a low forecast of 3.23 EUR and a high forecast of 4.87 EUR.
Shareholder Return
FAE Price
Faes Farma SA
Average Annual Return | 2.21% |
Standard Deviation of Annual Returns | 23.57% |
Max Drawdown | -42% |
Market Capitalization | 1.1B EUR |
Shares Outstanding | 313 629 400 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Faes Farma SA operates as a pharmaceutical company. The company is headquartered in Madrid, Madrid and currently employs 1,661 full-time employees. The firm specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The firm operates in Spain, Portugal, Chile and Mexico, among others. The company controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Contact
IPO
Employees
Officers
The intrinsic value of one FAE stock under the Base Case scenario is hidden EUR.
Compared to the current market price of 3.66 EUR, Faes Farma SA is hidden .